Clinical Trial Update: Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study of daridorexant for insomnia in patients with mild cognitive impairment and Alzheimer's disease, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Insomnia

Drugs mentioned

• QUVIVIQ (daridorexant)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Alzheimer Disease, Insomnia Disorder | Phase 4 | Status: RECRUITING